Altered resistive vessel function after coronary angioplasty is not due to reduced production of nitric oxide

Cardiovascular Research

Volumn 32, Issue 6, 1996, Pages 1108-1114

  Uren, Neal G ^a,b   Crake, Tom ^a   Lefroy, David C ^a   Davies, Graham J ^a   Maseri, Attilio ^a,c  

^a Div of Cardiol Hammersmith H L   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

coronary angioplasty; coronary blood flow; dipyridamole; human; nitrates; vasodilation

Indexed keywords

DIPYRIDAMOLE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; ENDOTHELIUM; HUMAN; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0030445464     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00160-5     Document Type: Article

References (36)

1. Zijlstra F, Reiber JHC, Juilliere Y, Serruys PW. Normalization of coronary flow reserve by percutaneous transluminal coronary angioplasty. Am J Cardiol. 61:1988;55-60.
2. Wilson RF, Johnson MR, Marcus ML, et al. The effect of coronary angioplasty on coronary flow reserve. Circulation. 77:1988;873-885.
3. Holdright DR, Clarke D, Poole-Wilson PA, Fox K, Collins P. Endothelium dependent and independent responses in coronary artery disease measured at angioplasty. Br Heart J. 70:1993;35-42.
4. Kern MJ, Deligonul U, Vandormael M, et al. Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux. J Am Coll Cardiol. 13:1989;860-872.
5. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function following coronary angioplasty. J Am Coll Cardiol. 21:1993;612-621.
6. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 83:1991;391-401.
7. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation. 81:1990;1586-1593.
8. Kuo L, Davis MJ, Cannon S, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ Res. 70:1992;465-476.
9. Drexler HE, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338:1991;1546-1550.
10. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
11. Epstein SE, Cannon RO III. Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. J Am Coll Cardiol. 8:1986;459-461.
12. Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG. Understanding the coronary circulation through studies at the microvascular level. Circulation. 82:1990;1-7.
13. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 17:1991;499-506.
14. Shirasaki Y, Su C. Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur J Pharmacol. 114:1985;93-96.
15. Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci. 88:1991;2166-2170.
16. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 139:1987;19-30.
17. West JW, Bellet S, Manzoli UC, Muller OF. Effects of Persantin, a new coronary vasodilator, on coronary blood flow and cardiac dynamics in the dog. Circ Res. 10:1962;35-42.
18. Klocke FJ. Measurement of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation. 76:1987;1183-1189.
19. Wilson RF, Laughlin DE, Ackell PH, et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation. 72:1985;82-92.
20. Reiber JHC, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation. 71:1985;280-288.
21. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
22. Wilson RF, Marcus ML, White CW. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation. 75:1987;723-732.
23. Fischell TA, Bausback KN, McDonald TV. Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty. J Clin Invest. 86:1990;575-584.
24. Bolli R, Triana F, Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for `microvascular stunning'. Circ Res. 67:1990;332-343.
25. Leppaluoto J, Ruskoaho H. Endothelin peptides: biological cellular signalling and clinical significance. Ann Med. 24:1992;153-161.
26. Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol. 250:1986;H509-H518.
27. Mills I, Fallon JT, Wrenn DS, Gray W, Bier J, Levine D, et al. Adaptive response of coronary circulation and myocardium to chronic reduction in perfusion pressure. Am J Physiol. 266:1994;H447-H457.
28. Maseri A, Crea F, Cianflone D. Myocardial ischemia caused by distal coronary vasoconstriction. Am J Cardiol. 70:1992;1602-1605.
29. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
30. Gattullo D, Linden RJ, Losano G, Pagliano P, Westerhof N. Coronary reactive hyperaemia after ischaemic preconditioning in the anaesthetised goat. J Physiol. 487:1995;168P. (Abstract).
31. Dupouy P, Geshwind H, Pelle G, et al. Repeated coronary artery occlusion during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol. 27:1996;1374-1380.
32. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Myocardial blood flow as a function of coronary stenosis severity in man. N Engl J Med. 330:1994;1782-1788.
33. Bartunek J, Sys SU, Heyndrickx GR, Pijls NH, De Bruyne B. Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol. 26:1995;328-334.
34. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 80:1991;1-9.
35. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 88:1993;43-54.
36. Vogel RA. Endothelium-dependent vasoregulation of coronary artery diameter and blood flow. Circulation. 88:1993;325-327.